Skip to content
TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25TTM Q3 '25
-$143.89M-9.4%-$131.48M-10.2%-$119.32M-4.8%-$113.81M-32.0%-$86.23M+2.0%
$8.22M+1.2%$8.13M+6.6%$7.62M-4.4%$7.97M-11.7%$9.02M-10.0%
$45.65M+26.8%$36M+26.5%$28.47M+17.3%$24.27M+942%$2.33M+3.9%
-$87.04M-0.4%-$86.67M-0.3%-$86.38M-11.3%-$77.61M-8.4%-$71.61M+0.1%
$32.62M+21.3%$26.88M+11.7%$24.07M+4.9%$22.94M+23.3%$18.6M+5.7%
-$37.98M-38.1%-$27.51M-12.2%-$24.51M-5.1%-$23.31M-22.9%-$18.96M-7.9%
$361.98M
$236.97M
-$119.66M-5.4%-$113.55M-2.8%-$110.45M-9.9%-$100.54M-11.5%-$90.21M-1.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Kestra Medical Technologies, Ltd. Common Stock generate?
Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated -$87.0M in operating cash flow over the trailing twelve months.
What is Kestra Medical Technologies, Ltd. Common Stock's free cash flow?
After $32.6M of capital expenditures, Kestra Medical Technologies, Ltd. Common Stock's free cash flow was -$119.7M over the trailing twelve months, down 32.6% year over year.
Where does Kestra Medical Technologies, Ltd. Common Stock's cash flow data come from?
Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.